Zealand Pharma

ZLDPF · Soborg, Denmark

Works in Genetic & rare · GI & liver · Immunology · Metabolic & endocrine · Renal & urogenital · Women's health

Zealand Pharma is a clinical trial sponsor based in Soborg, Denmark, listed as ZLDPF. It has 6 active clinical trials with 398 planned participants, across 6 therapeutic areas. Since 2021 it has completed 24 trials and stopped 2 early.

Trial track record · since 2021

6Active trials398 planned participants
24Completed10 with results posted
2Stopped early8% of finished trials

Financials · ZLDPF

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

No SEC Form D filings under this name. A private round is only public when the company files one.

Pipeline · 6 active trials

StageTrialStatus

On the market · 0 products

No marketed products under this name.

Questions about Zealand Pharma

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-29.

Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-10-23.

Approve Suite is not affiliated with Zealand Pharma.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.